Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0U7UD
|
||||
Former ID |
DNC011043
|
||||
Drug Name |
5-chloro-N-(pyridin-3-yl)indoline-1-carboxamide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [551219] | ||
Structure |
Download2D MOL |
||||
Formula |
C14H12ClN3O
|
||||
Canonical SMILES |
C1CN(C2=C1C=C(C=C2)Cl)C(=O)NC3=CN=CC=C3
|
||||
InChI |
1S/C14H12ClN3O/c15-11-3-4-13-10(8-11)5-7-18(13)14(19)17-12-2-1-6-16-9-12/h1-4,6,8-9H,5,7H2,(H,17,19)
|
||||
InChIKey |
BYXYRVSXGVLRKM-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 2A receptor | Target Info | Inhibitor | [551219] | |
5-hydroxytryptamine 2C receptor | Target Info | Inhibitor | [551219] | ||
WikiPathways | Serotonin Receptor 2 and STAT3 Signaling | ||||
Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
SIDS Susceptibility Pathways | |||||
Monoamine GPCRs | |||||
GPCRs, Class A Rhodopsin-like | |||||
Gastrin-CREB signalling pathway via PKC and MAPK | |||||
GPCR ligand binding | |||||
GPCR downstream signaling | |||||
GPCRs, OtherWP732:Serotonin Receptor 2 and ELK-SRF/GATA4 signaling | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.